Efficacy and safety of LY3298176 (tirzepatide), a novel dual GIP and GLP-1 receptor agonist, in patients with type 2 diabetes (Phase 2 trial)
PubMed Central, Zalups, R
The compound remains at preclinical stages [14]
Quick Answer: RxSpan MD is a telehealth platform, not a drug, so this splits in two: the platform's job is connecting you to licensed care, and the medications it offers belong to a class with substantial published evidence behind the FDA-approved finished products
Zepbound (Tirzepatide) Zepbound combines the power of two hormones, GLP-1 and GIP, for optimal weight reduction
Certain medical conditions or other factors may further increase the risk of this side effect